Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.

MLA

Mueller, Jessica L., et al. “Impact of EGF, IL28B, and PNPLA3 Polymorphisms on the Outcome of Allograft Hepatitis C: A Multicenter Study.” Clinical Transplantation, vol. 30, no. 4, Apr. 2016, pp. 452–60. EBSCOhost, https://doi.org/10.1111/ctr.12710.

APA

Mueller, J. L., King, L. Y., Johnson, K. B., Gao, T., Nephew, L. D., Kothari, D., Simpson, M. A., Zheng, H., Wei, L., Corey, K. E., Misdraji, J., Lee, J. H., Lin, M. V., Gogela, N. A., Fuchs, B. C., Tanabe, K. K., Gordon, F. D., Curry, M. P., & Chung, R. T. (2016). Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. Clinical Transplantation, 30(4), 452–460. https://doi.org/10.1111/ctr.12710

Chicago

Mueller, Jessica L, Lindsay Y King, Kara B Johnson, Tian Gao, Lauren D Nephew, Darshan Kothari, Mary Ann Simpson, et al. 2016. “Impact of EGF, IL28B, and PNPLA3 Polymorphisms on the Outcome of Allograft Hepatitis C: A Multicenter Study.” Clinical Transplantation 30 (4): 452–60. doi:10.1111/ctr.12710.